Genetic,Testing,Early,Diagnosi marketing Genetic Testing - Early Diagnosis of Genetic disorders
Automation technologies represent a fundamental aspect of any modern industry. The major types of industrial automation solutions, such as DCS, PLC, SCADA, and MES, are used on a large-scale in process and discrete industries.DCS technologie Awhile ago, I got an email from one of the "gurus" I follow and it shocked me. The gist of it was this person wanted to trade services for a household item.To say it floored me would be an understatement.What was worse was a few days later t
Genetic testing is the most rapidly growing segment of the universal molecular diagnostics market. Rising incidences of genetic diseases have triggered new opportunities for genetic testing. The revolution of genetic testing from being a service-driven market to a product-driven market is expected to provide an impetus to diagnostic companies for the innovative technologies and thus, expanding into different market. Cytogenetics, Molecular Genetics, Cancer Genetics, Prenatal tests are the most common type of genetic tests. This involves examining an individual's genetic material taken from cells in a sample of blood or from other body fluids or tissues.Genetic testing refers to the analysis of DNA which helps to identify changes in gene sequence or expression levels. It can also refer to biochemical tests for proteins (gene products) and for the karyotyping (microscopic analysis of stained chromosomes). Still in its early stages, both patients and experienced physicians may need guidance when it comes to navigating this new and complex territory. The United States cancer testing market size alone is estimated to be roughly $10-12 billion. The prevalence of cancer is expected to increase as the US population ages. Approximately 75-80% of all cancers are diagnosed in people aged 55 or older and this pattern is expected to increase by 2020. The global share of senior citizens (aged 60 years or over) will continue to grow. With the ailments currently afflicting humans in mind, this trend projects cancer as the fastest growing segment of genetic testing across the globe.The genetic testing market is dominated by a few large public companies that have recently consolidated numerous smaller players in the industry. There are approximately 300 genetic laboratories in the US, out of which, 80% are committed with academic institutions and are focused on research and institutional needs. Approximately 120+ companies have new pipeline products in development for different indications.Over 1,500 genetic tests are available in the market and the number of these tests are forecasted to increase by 25% annually, and about 300 more genetic tests are available purely on research basis. The procedure are at very low risk. Usually they are done on a sample of blood, cheek cells, urine, amniotic fluid (the fluid that surrounds a fetus during pregnancy) or other body tissues. For cancer, several tubes of blood are collected through a thin needle inserted into a vein (usually in the arm) to get blood.With the guide strategy for the genetic test, aims mainly to prevent genetic disorders. The advantage of these tests is the identification of several types of genes, which can cause inherited susceptibility to disease; if inherited in a faulty state.The integration of genetic testing into clinical practice provides multiple benets to individuals in families with histories of genetic disorders. The benefits include earlier detection of genetic disorders and prevention of these disorders, providing greater choice of surgical and other intervention options and provision of information for planning family, career decisions. In hereditary disorders, genetic testing has been shown to be cost-effective. Article Tags: Disorders Genetic Testing, Genetic Testing, Genetic Disorders, Disorders Genetic, Genetic Tests
Genetic,Testing,Early,Diagnosi